Development of a microrna-responsive system accelerates synthesis of photosensitizers, improving cancer therapy. This work highlights precise controllability in structure and kinetics.
The selectively in situ synthesis and activation of therapeutic agents within tumor cells are critical for enhancing the targetability and preciseness of cancer therapy. Herein, triggering by specific tumor microRNA biomarker, programmed hybridization-chain reaction (HCR) assemblies of aggregation-induced emission (AIE) photosensitizers were conducted for the in situ, rapid and controllable synthesis of anticancer agents in cancer cells. Robust fluorescence and photodynamic activities were thus provoked from scratch for precise cancer therapy. By precisely tuning the DNA valency conjugated to the photosensitizer, controllable assembly of one-dimensional linear-, two-dimensional dendritic-, and three-dimensional stereo-type structures were achieved, in which the two-dimensional assembly showing the greatest gains in the turn-on fluorescence and reactive oxygen species (ROS) signals. Notably, the photosensitizer conjugation significantly accelerated the HCR kinetics of hairpin DNAs, thereby facilitating the rapid response to microRNA biomarker within tumor cells and tissues. This microRNA-responsive kinetics-accelerated and dimension-controllable assembly strategy, provides a new avenue for in situ precise cancer theranostics.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: